: Pathology registers can be a useful tool to overcome obstacles in the identification and management of familial hypercholesterolemia since childhood. In 2018, the LIPIGEN pediatric group was constituted within the Italian LIPIGEN study to focus on FH subjects under 18 years. This work aimed at discussing its recent progress and early outcomes. Demographic, biochemical, and genetic baseline characteristics were collected, with an in-depth analysis of the genetic defects. The analysis was carried out on 1,602 children and adolescents (mean age at baseline 9.9 ± 4.0 years), and almost the whole cohort underwent the genetic test (93.3%). Overall, the untreated mean value of LDL-C was 220.0 ± 97.2 mg/dl, with an increasing gradient from subjects with a negative (N = 317; mean untreated LDL-C = 159.9 ± 47.7 mg/dl), inconclusive (N = 125; mean untreated LDL-C = 166.4 ± 56.5 mg/dl), or positive (N = 1,053; mean untreated LDL-C = 246.5 ± 102.1 mg/dl) genetic diagnosis of FH. In the latter group, the LDL-C values presented a great variability based on the number and the biological impact of involved causative variants. The LIPIGEN pediatric group represents one of the largest cohorts of children with FH, allowing the deepening of the characterization of their baseline and genetic features, providing the basis for further longitudinal investigations for complete details.

The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group / Gazzotti, Marta; Casula, Manuela; Bertolini, Stefano; Capra, Maria Elena; Olmastroni, Elena; Catapano, Alberico Luigi; Cristina, Pederiva; LIPIGEN Paediatric Group: Massimiliano Allevi, ; Arca, Marcello; Auricchio, Renata; Averna, Maurizio; Baldera, Davide; Banderali, Giuseppe; Bartuli, Andrea; Bertolini, Stefano; Biasucci, Giacomo; Borghi, Claudio; Bruzzi, Patrizia; Buganza, Raffaele; Paola Sabrina Buonuomo, ; Calabrò, Paolo; Calandra, Sebastiano; Maria Elena Capra, ; Carubbi, Francesca; Casula, Manuela; Alberico Luigi Catapano, ; Cesaro, Arturo; Cipollone, Francesco; Citroni, Nadia; Covetti, Giuseppe; Cremonini, Annalaura; D'Addato, Sergio; Maria Del Ben, ; DI TARANTO, MARIA DONATA; Fortunato, Giuliana; Franceschi, Roberto; Galimberti, Federica; Gazzotti, Marta; Genovesi, Simonetta; Giammanco, Antonina; Grigore, Liliana; Guardamagna, Ornella; Iannuzzi, Arcangelo; Iannuzzo, Gabriella; Iughetti, Lorenzo; Lascala, Lidia; Locatelli, Fabiana; Madaghiele, Sara; Mandraffino, Giuseppe; Massimo Raffaele Mannarino, ; Marco, Bucci; Maroni, Lorenzo; Minicocci, Ilenia; Mombelli, Giuliana; Muntoni, Sandro; Nascimbeni, Fabio; Olmastroni, Elena; Parati, Gianfranco; Passaro, Angelina; Pavanello, Chiara; Pederiva, Cristina; Pellegatta, Fabio; Francesco Massimo Perla, ; Pirro, Matteo; Pisciotta, Livia; Pujia, Arturo; Purrello, Francesco; Rinaldi, Elisabetta; Sarzani, Riccardo; Scicali, Roberto; Suppressa, Patrizia; Tarugi, Patrizia; Verachtert, Sabrina; Giovanni Battista Vigna, ; Josè Pablo Werba, ; Zambon, Alberto; Zambon, Sabina; Maria Grazia Zenti,. - In: FRONTIERS IN GENETICS. - ISSN 1664-8021. - 13:(2022), p. 912510. [10.3389/fgene.2022.912510]

The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group

Olmastroni, Elena;Marcello Arca;Renata Auricchio;Maurizio Averna;Giuseppe Covetti;Maria Donata Di Taranto;Giuliana Fortunato;Gabriella Iannuzzo;Elena Olmastroni;Francesco Purrello;
2022

Abstract

: Pathology registers can be a useful tool to overcome obstacles in the identification and management of familial hypercholesterolemia since childhood. In 2018, the LIPIGEN pediatric group was constituted within the Italian LIPIGEN study to focus on FH subjects under 18 years. This work aimed at discussing its recent progress and early outcomes. Demographic, biochemical, and genetic baseline characteristics were collected, with an in-depth analysis of the genetic defects. The analysis was carried out on 1,602 children and adolescents (mean age at baseline 9.9 ± 4.0 years), and almost the whole cohort underwent the genetic test (93.3%). Overall, the untreated mean value of LDL-C was 220.0 ± 97.2 mg/dl, with an increasing gradient from subjects with a negative (N = 317; mean untreated LDL-C = 159.9 ± 47.7 mg/dl), inconclusive (N = 125; mean untreated LDL-C = 166.4 ± 56.5 mg/dl), or positive (N = 1,053; mean untreated LDL-C = 246.5 ± 102.1 mg/dl) genetic diagnosis of FH. In the latter group, the LDL-C values presented a great variability based on the number and the biological impact of involved causative variants. The LIPIGEN pediatric group represents one of the largest cohorts of children with FH, allowing the deepening of the characterization of their baseline and genetic features, providing the basis for further longitudinal investigations for complete details.
2022
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group / Gazzotti, Marta; Casula, Manuela; Bertolini, Stefano; Capra, Maria Elena; Olmastroni, Elena; Catapano, Alberico Luigi; Cristina, Pederiva; LIPIGEN Paediatric Group: Massimiliano Allevi, ; Arca, Marcello; Auricchio, Renata; Averna, Maurizio; Baldera, Davide; Banderali, Giuseppe; Bartuli, Andrea; Bertolini, Stefano; Biasucci, Giacomo; Borghi, Claudio; Bruzzi, Patrizia; Buganza, Raffaele; Paola Sabrina Buonuomo, ; Calabrò, Paolo; Calandra, Sebastiano; Maria Elena Capra, ; Carubbi, Francesca; Casula, Manuela; Alberico Luigi Catapano, ; Cesaro, Arturo; Cipollone, Francesco; Citroni, Nadia; Covetti, Giuseppe; Cremonini, Annalaura; D'Addato, Sergio; Maria Del Ben, ; DI TARANTO, MARIA DONATA; Fortunato, Giuliana; Franceschi, Roberto; Galimberti, Federica; Gazzotti, Marta; Genovesi, Simonetta; Giammanco, Antonina; Grigore, Liliana; Guardamagna, Ornella; Iannuzzi, Arcangelo; Iannuzzo, Gabriella; Iughetti, Lorenzo; Lascala, Lidia; Locatelli, Fabiana; Madaghiele, Sara; Mandraffino, Giuseppe; Massimo Raffaele Mannarino, ; Marco, Bucci; Maroni, Lorenzo; Minicocci, Ilenia; Mombelli, Giuliana; Muntoni, Sandro; Nascimbeni, Fabio; Olmastroni, Elena; Parati, Gianfranco; Passaro, Angelina; Pavanello, Chiara; Pederiva, Cristina; Pellegatta, Fabio; Francesco Massimo Perla, ; Pirro, Matteo; Pisciotta, Livia; Pujia, Arturo; Purrello, Francesco; Rinaldi, Elisabetta; Sarzani, Riccardo; Scicali, Roberto; Suppressa, Patrizia; Tarugi, Patrizia; Verachtert, Sabrina; Giovanni Battista Vigna, ; Josè Pablo Werba, ; Zambon, Alberto; Zambon, Sabina; Maria Grazia Zenti,. - In: FRONTIERS IN GENETICS. - ISSN 1664-8021. - 13:(2022), p. 912510. [10.3389/fgene.2022.912510]
File in questo prodotto:
File Dimensione Formato  
fgene-13-912510.pdf

accesso aperto

Licenza: Creative commons
Dimensione 812.55 kB
Formato Adobe PDF
812.55 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/937707
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact